Associations of estradiol and testosterone with serum phosphorus in older men: the Osteoporotic Fractures in Men study.

[1]  S. Cummings,et al.  Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study. , 2010, American journal of epidemiology.

[2]  J. Cannata-Andía,et al.  Indirect regulation of PTH by estrogens may require FGF23. , 2009, Journal of the American Society of Nephrology : JASN.

[3]  B. Kestenbaum,et al.  Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  B. Kestenbaum,et al.  Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[5]  R. Foley,et al.  Serum phosphorus levels associate with coronary atherosclerosis in young adults. , 2009, Journal of the American Society of Nephrology : JASN.

[6]  L. Shaw,et al.  Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality. , 2008, American journal of epidemiology.

[7]  D. Mellström,et al.  Relation between fibroblast growth factor-23, body weight and bone mineral density in elderly men , 2009, Osteoporosis International.

[8]  D. Mellström,et al.  Older Men With Low Serum Estradiol and High Serum SHBG Have an Increased Risk of Fractures , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[9]  R. Foley,et al.  Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. , 2008, American heart journal.

[10]  M. Levi,et al.  Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. , 2008, Kidney international.

[11]  W. Cates Age, Renal Tubular Phosphate Reabsorption, and Serum Phosphate Levels in Adults , 2008 .

[12]  D. Mellström,et al.  Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men. , 2008, European journal of endocrinology.

[13]  L. Quarles,et al.  How fibroblast growth factor 23 works. , 2007, Journal of the American Society of Nephrology : JASN.

[14]  R. D'Agostino,et al.  Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. , 2007, Archives of internal medicine.

[15]  B. Leder,et al.  Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. , 2007, Bone.

[16]  E. Barrett-Connor,et al.  Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones , 2007, International Journal of Obesity.

[17]  H. Murer,et al.  Proximal tubular handling of phosphate: A molecular perspective. , 2006, Kidney international.

[18]  Evan R. Simpson,et al.  Of mice and men: the evolving phenotype of aromatase deficiency , 2006, Trends in Endocrinology & Metabolism.

[19]  M. Pfeffer,et al.  Relation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease , 2005, Circulation.

[20]  S. Cummings,et al.  Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men. , 2005, Contemporary clinical trials.

[21]  P. Cawthon,et al.  Overview of recruitment for the osteoporotic fractures in men study (MrOS). , 2005, Contemporary clinical trials.

[22]  J. M. Guralnik,et al.  Drug data coding and analysis in epidemiologic studies , 1994, European Journal of Epidemiology.

[23]  S. Adami,et al.  The effects of menopause and estrogen replacement therapy on the renal handling of calcium , 1992, Osteoporosis International.

[24]  H. Caffier,et al.  Steroid hormone binding receptors in the rat kidney , 2004, Histochemistry.

[25]  G. Eknoyan,et al.  National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.

[26]  Y. Takeuchi,et al.  Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. , 2002, The Journal of clinical endocrinology and metabolism.

[27]  M. McKee,et al.  Phosphate regulation of vascular smooth muscle cell calcification. , 2000, Circulation research.

[28]  David Roth,et al.  A simplified equation to predict glomerular filtration rate from serum creatinine , 2000 .

[29]  H. Uemura,et al.  Close correlation between estrogen treatment and renal phosphate reabsorption capacity. , 2000, The Journal of clinical endocrinology and metabolism.

[30]  R. Auchus,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society COMMENTARY Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action* , 2022 .

[31]  A. Vermeulen,et al.  A critical evaluation of simple methods for the estimation of free testosterone in serum. , 1999, The Journal of clinical endocrinology and metabolism.

[32]  H. Tenenhouse,et al.  Effects of Npt2 gene ablation and low-phosphate diet on renal Na(+)/phosphate cotransport and cotransporter gene expression. , 1999, The Journal of clinical investigation.

[33]  N. Amizuka,et al.  Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Vanderschueren,et al.  Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. , 1992, Endocrinology.

[35]  J. Coderre,et al.  Effects of estrogen on mineral metabolism in postmenopausal women as evaluated by multiple assays measuring parathyrin bioactivity. , 1989, Clinical chemistry.

[36]  L. Mallette,et al.  Effects of a short course of estrogen on mineral metabolism in postmenopausal women. , 1985, The Journal of clinical endocrinology and metabolism.

[37]  S. Ralston,et al.  Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy. , 1984, Maturitas.

[38]  T. Bäckström,et al.  Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. , 1982, Journal of steroid biochemistry.

[39]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.